DNA profiling kits market seen reaching $2.48 billion by 2030

The DNA profiling kits market is projected to grow from $1.4 billion in 2025 to $2.48 billion by 2030, driven by forensic demand, personalized medicine and faster genetic analysis tools. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - DNA profiling kits are becoming more central to forensics, healthcare and consumer genetic testing as genetic analysis gets faster and more precise. - The market’s growth signals rising demand for tools that can identify individuals, establish biological relationships and support targeted treatment decisions.

What happened: - The global DNA profiling kits market is projected to rise from $1.4 billion in 2025 to $1.57 billion in 2026. - The market is forecast to reach $2.48 billion by 2030. - The forecast implies a 11.9% CAGR from 2025 to 2026 and a 12.2% CAGR from 2026 to 2030. - The Business Research Company published the outlook on July 1, 2026. - The company also made a free sample report and the full market report available.

The details: - DNA profiling kits analyze genetic material to identify individuals and establish biological relationships. - The kits include reagents and components used for DNA extraction, amplification and examination of specific DNA regions. - The kits are used in forensic investigations, paternity testing and genetic research. - Historical growth has been driven by wider use of forensic science in law enforcement. - Demand has also risen from paternity and kinship testing, greater adoption of polymerase chain reaction technology and more government funding for forensic infrastructure. - Standardized DNA testing protocols in clinical research have also supported the market. - The next growth phase is tied to next-generation sequencing, personalized medicine, genetic diagnostics and AI-powered genetic data interpretation. - Direct-to-consumer genetic testing and automated, high-throughput DNA analysis systems are also expected to expand use. - Major trends include NGS-based kits, rapid forensic DNA testing, automated extraction and amplification, consumer ancestry testing and cloud-based genetic data platforms.

Between the lines: - Personalized medicine is becoming a major commercial driver because healthcare providers are using genetic differences to tailor prevention, diagnosis and treatment. - A February 2024 update from the Personalized Medicine Coalition said 16 new personalized treatments for rare diseases received FDA approval in 2023, up from six in 2022. - That jump shows how faster approval of targeted therapies is feeding demand for genetic analysis tools. - North America held the largest market share in 2025, reflecting strong adoption in forensic and healthcare settings. - Asia-Pacific is expected to post the fastest growth as healthcare infrastructure investment and awareness of genetic testing rise. - The report also covers South East Asia, Western Europe, Eastern Europe, South America and the Middle East and Africa.

What’s next: - The market is likely to keep shifting toward higher-throughput, more automated and more secure genetic testing workflows. - Cloud-based platforms and AI-assisted interpretation should become more important as genetic data volumes grow. - The Business Research Company said its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards and market hotspot infographics.

The bottom line: - DNA profiling kits are moving from a niche forensic tool to a broader genetic testing platform, with personalized medicine and advanced sequencing expected to drive the next wave of growth.